Pre-market
Exercise
Calculated transaction value
$0

Rubinstein Julie President And COO

Transaction date Oct 8, 2026
Public filing date Oct 8, 2026
Filing lag Filed same day

ADPT daily price context

Close on/before transaction
$26.09 Oct 8, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option (right to buy) on Common Stock
Quantity / price
11,881 shares @ $0
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001780664-26-000037
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.38M
Buys / sales
0 / 6
Transactions reported in the same official filing
Issuer Transaction Traded Value
Adaptive Biotechnologies Corp ADPT Exercise Oct 8, 2026 $144.24K
Adaptive Biotechnologies Corp ADPT Sale Oct 8, 2026 $304.87K
Adaptive Biotechnologies Corp ADPT Current Exercise Oct 8, 2026 $0
Adaptive Biotechnologies Corp ADPT Sale Oct 7, 2026 $313.66K
Adaptive Biotechnologies Corp ADPT Exercise Oct 7, 2026 $144.24K
Adaptive Biotechnologies Corp ADPT Exercise Oct 7, 2026 $0
Adaptive Biotechnologies Corp ADPT Sale Oct 6, 2026 $256.66K
Adaptive Biotechnologies Corp ADPT Exercise Oct 6, 2026 $0
Adaptive Biotechnologies Corp ADPT Exercise Oct 6, 2026 $144.24K
Adaptive Biotechnologies Corp ADPT Sale Oct 6, 2026 $26.77K
Adaptive Biotechnologies Corp ADPT Sale Oct 6, 2026 $15.23K
Adaptive Biotechnologies Corp ADPT Sale Oct 6, 2026 $31.03K